Cell therapy for cardiovascular disease: What cells, what diseases and for whom?

Nature Clinical Practice Cardiovascular Medicine

Volumn 2, Issue 1, 2005, Pages 37-43

  Caplice, Noel M ^a,b   Gersh, Bernard J ^a   Alegria, Jorge R ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cardiac repair; Cell therapy; Progenitors; Vascular repair

Indexed keywords

ACUTE HEART INFARCTION; ANGIOGENESIS; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL TRANSPLANTATION; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUSCLE REGENERATION; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT INDICATION;

CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; HUMANS; MYOCARDIAL ISCHEMIA; PERIPHERAL VASCULAR DISEASES; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 20444498325     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0073     Document Type: Review

References (50)

1. Kuehnle I and Goodell MA (2002) The therapeutic potential of stem cells from adults. BMJ 325: 372-376
2. Wagers AJ et al. (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297: 2256-2259
3. Pittenger MF et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147
4. Zuk PA et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295
5. Beltrami AP et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776
6. Menasche P (2004) Cellular transplantation: hurdles remaining before widespread clinical use. Curr Opin Cardiol 19: 154-161
7. Taylor DA et al. (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4: 929-933
8. Pagani FD et al. (2003) Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879-888
9. Menasche P et al. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41: 1078-1063
10. Wollert KC et al. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148
11. Assmus B et al. (2002) Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 3009-3017
12. Orlic D et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705
13. Jackson KA et al. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402
14. Murry CE et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-666
15. Yoon Y-S et al. (2004) Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial Infarction. Circulation 109: 3154-3157
16. Toma C et al. (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98
17. Jiang Y et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49
18. Makino S et al. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705
19. Mangi AA et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201
20. Asahara T et al. (1997) Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science 275: 964-966
21. Shi Q et al. (1998) Evidence for Circulating Bone Marrow-Derived Endothelial Cells. Blood 92: 362-367
22. - Blood-Derived Human Endothelial Cell Progenitors. Stem Cells 19: 304-312
23. Rehman et al. (2003) Peripheral Blood "Endothelial Progenitor Cells" Are Derived From Monocyte/ Macrophages and Secrete Angiogenic Growth Factors. Circulation 107: 1164-1169
24. Badorff C et al. (2003) Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024-1032
25. + cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 18: 1737-1739 [doi: 10.1096/fj.04-2192fje]
26. Nowak G et al. (2004) Expression of Vascular Endothelial Growth Factor Receptor-2 or Tie-2 on Peripheral Blood Cells Defines Functionally Competent Cell Populations Capable of Reendothelialization. Circulation [doi: 10.1161/01.CIR.0000143626.16576.51]
27. Rehman J et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-1298
28. Majka SM et al. (2003) Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111: 71-79
29. + progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 44: 458-463
30. Caplice NM et al. (2003) Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 100: 4754-4759
31. Galinanes M et al. (2004) Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 13: 7-13
32. Tse HF et al. (2003) Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361: 47-49
33. Perin EC et al. (2003) Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure. Circulation 107: 2294-2302
34. Strauer BE et al. (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913-1918
35. Britten MB et al. (2003) Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging. Circulation 108: 2212-2218
36. Schachinger V et al. (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690-1699
37. Fernandez-Aviles F et al. (2004) Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction. Circ Res 95: 742-748
38. Hamano K et al. (2001) Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65: 845-847
39. Fuchs S et al. (2003) Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: A feasibility study. J Am Coll Cardiol 41: 1721-1724
40. Pouly J et al. (2004) Does the Functional Efficacy of Skeletal Myoblast Transplantation Extend to Nonischemic Cardiomyopathy? Circulation 110: 1626-1631
41. Tateishi-Yuyama E et al. (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435
42. Hill JM et al. (2003) Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. N Engl J Med 348: 593-600
43. Rauscher FM et al. (2003) Aging, Progenitor Cell Exhaustion, and Atherosclerosis. Circulation 108: 457-463
44. Tepper OM et al. (2002) Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures. Circulation 106: 2781-2786
45. Heeschen C et al. (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622
46. Kang HJ et al. (2004) Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363: 751-756
47. Singh SK et al. (2003) Identification of a Cancer Stem Cell in Human Brain Tumors. Cancer Res 63: 5821-5828
48. Vulliet PR et al. (2004) Intracoronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363: 783-784
49. Laufs U et al. (2004) Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis. Circulation 109: 220-226
50. Vasa M et al. (2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890